829 related articles for article (PubMed ID: 6976185)
21. Regulation of factor IXa in vitro in human and mouse plasma and in vivo in the mouse. Role of the endothelium and the plasma proteinase inhibitors.
Fuchs HE; Trapp HG; Griffith MJ; Roberts HR; Pizzo SV
J Clin Invest; 1984 Jun; 73(6):1696-703. PubMed ID: 6202716
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the P2' and P3' specificities of thrombin using fluorescence-quenched substrates and mapping of the subsites by mutagenesis.
Le Bonniec BF; Myles T; Johnson T; Knight CG; Tapparelli C; Stone SR
Biochemistry; 1996 Jun; 35(22):7114-22. PubMed ID: 8679538
[TBL] [Abstract][Full Text] [Related]
23. On the activation of bovine plasma factor XIII. Amino acid sequence of the peptide released by thrombin and the terminal residues of the subunit polypeptides.
Nakamura S; Iwanaga S; Suzuki T
J Biochem; 1975 Dec; 78(6):1247-66. PubMed ID: 1225922
[TBL] [Abstract][Full Text] [Related]
24. Serine protease specificity for peptide chromogenic substrates.
Mattler LE; Bang NU
Thromb Haemost; 1977 Dec; 38(4):776-92. PubMed ID: 146272
[TBL] [Abstract][Full Text] [Related]
25. Determination of the P1', P2' and P3' subsite-specificity of factor Xa.
Ludeman JP; Pike RN; Bromfield KM; Duggan PJ; Cianci J; Le Bonniec B; Whisstock JC; Bottomley SP
Int J Biochem Cell Biol; 2003 Feb; 35(2):221-5. PubMed ID: 12479872
[TBL] [Abstract][Full Text] [Related]
26. Role of heparin and heparinlike molecules in thrombosis and atherosclerosis.
Rosenberg RD
Fed Proc; 1985 Feb; 44(2):404-9. PubMed ID: 3155697
[TBL] [Abstract][Full Text] [Related]
27. The esterolytic specificity of bovine thrombin and Factor Xa.
Lonsdale-Eccles JD; Hogg DH; Elmore DT
Biochim Biophys Acta; 1980 Apr; 612(2):395-400. PubMed ID: 7370278
[TBL] [Abstract][Full Text] [Related]
28. [Prothrombin--substrate for blood plasma kallikrein and factor XIIa].
Baskova IP; Tiero A; Krizhevskaia IuV; Iarovaia GA; Mirkamalova EG
Biull Eksp Biol Med; 1983 Aug; 96(8):13-6. PubMed ID: 6603874
[TBL] [Abstract][Full Text] [Related]
29. New class of sensitive and selective fluorogenic substrates for serine proteinases. Amino acid and dipeptide derivatives of rhodamine.
Leytus SP; Patterson WL; Mangel WF
Biochem J; 1983 Nov; 215(2):253-60. PubMed ID: 6228222
[TBL] [Abstract][Full Text] [Related]
30. Coagulation factor IX residues G4-Q11 mediate its interaction with a shared factor IX/IXa binding site on activated platelets but not the assembly of the functional factor X activating complex.
Ahmad SS; Wong MY; Rawala R; Jameson BA; Walsh PN
Biochemistry; 1998 Feb; 37(6):1671-9. PubMed ID: 9484238
[TBL] [Abstract][Full Text] [Related]
31. A new sensitive assay for bovine activated factor XI (factor XIa) using a reconstituted coagulation cascade system.
Kato H; Nakagaki T; Morita T; Kisiel W; Iwanaga S
Thromb Res; 1987 Nov; 48(4):461-74. PubMed ID: 3502201
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of thrombin by arginine-containing peptide chloromethyl ketones and bis chloromethyl ketone-albumin conjugates.
Odake S; Kam CM; Powers JC
J Enzyme Inhib; 1995; 9(1):17-27. PubMed ID: 8568563
[TBL] [Abstract][Full Text] [Related]
33. Interaction of type 1 plasminogen activator inhibitor with the enzymes of the contact activation system.
Berrettini M; Schleef RR; España F; Loskutoff DJ; Griffin JH
J Biol Chem; 1989 Jul; 264(20):11738-43. PubMed ID: 2787318
[TBL] [Abstract][Full Text] [Related]
34. Protein products of the rat kallikrein gene family. Substrate specificities of kallikrein rK2 (tonin) and kallikrein rK9.
Moreau T; Brillard-Bourdet M; Bouhnik J; Gauthier F
J Biol Chem; 1992 May; 267(14):10045-51. PubMed ID: 1315752
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and hydrolysis by cysteine and serine proteases of short internally quenched fluorogenic peptides.
Melo RL; Alves LC; Del Nery E; Juliano L; Juliano MA
Anal Biochem; 2001 Jun; 293(1):71-7. PubMed ID: 11373081
[TBL] [Abstract][Full Text] [Related]
36. Comparative specificity of porcine pancreatic kallikrein and bovine pancreatic trypsin. Importance of interactions N-terminal to the scissible bond.
Bizzozero SA; Dutler H
Arch Biochem Biophys; 1987 Aug; 256(2):662-76. PubMed ID: 3650053
[TBL] [Abstract][Full Text] [Related]
37. New chromogenic substrates for thrombin with increased specificity.
Kolde HJ; Eberle R; Heber H; Heimburger N
Thromb Haemost; 1986 Oct; 56(2):155-9. PubMed ID: 2949389
[TBL] [Abstract][Full Text] [Related]
38. Cleavage at arginine 145 in human blood coagulation factor IX converts the zymogen into a factor VIII binding enzyme.
Lenting PJ; ter Maat H; Clijsters PP; Donath MJ; van Mourik JA; Mertens K
J Biol Chem; 1995 Jun; 270(25):14884-90. PubMed ID: 7797466
[TBL] [Abstract][Full Text] [Related]
39. Kinetic comparison of bovine blood coagulation factors IXa alpha and IXa beta toward bovine factor X.
Link RP; Castellino FJ
Biochemistry; 1983 Aug; 22(17):4033-41. PubMed ID: 6412750
[TBL] [Abstract][Full Text] [Related]
40. Mechanism of surface-mediated activation of bovine Factor XII and prekallikrein.
Sugo T; Ohno Y; Shimada T; Kato H; Iwanaga S
Adv Exp Med Biol; 1983; 156():87-107. PubMed ID: 6602465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
